allopurinol
probeneci
d
Hyperuricemia
colchicine
Crystals in tophi
1963
1961 McCarty
1950 Talbott et al
1848 Garrod
Gout
1814
1798 Wollastone
Urate crystal
History of Gout
Middle-Age
Genetics & Lifestyle
Purine metabolism, overproduction
(10%) or underexcretion (90%)
Urate crystalization
Hyperuricemia
Genetic factor
Environments
Presentation/Diagnosis
Aspiration of Synovial Fluid
needle-shaped monosodium urate
crystals with negative birefringence.
Diagnosis
24 hour uric acid level
>800 mg = overproduction
<600 mg = underexcretion
Normal uric acid in the blood:
( 2.5 6 mg/dl)
Definition of hyperuricemia
Mean serum urate concentration in normal
adult:
5.11.0mg/dl( ), 4.01.0mg/dl(
)
Limit of solubility of MSU
6.7mg/dl at 37 C
Hyperuricemia
> 7.0mg/dl(
), > 6.0mg/dl(
)
A Musculoskeletal disease
Low-Purine Diet
Avoid Vitamin C
High Dose Colchicine
Avoid HCT ( Hidrochlorthiazide):
diuretic
Gout 2011
Profound Metabolic Consequences!
linked to obesity, hypertension, dyslipidemia,
insulin resistance, hyperglycemia, and
coronary artery disease.[3]
NHANES III Metabolic Syndrome in 62.8%
with gout vs. 25.4% without
Framingham Study - independent 60%
increased risk of coronary artery disease in
men with gout, after controlling for other
factors.[5]
Mechanism?
Gouty Tophi
Incidence has decreased over last few decades
Seen in 25-50% of untreated patients (after 1020yrs)
Location: Olecranon, bursae, digits, helix of ear
Damages bone, periarticular structures and soft
tissues
Palpable measure of total body urate load
Other Extraarticular Complications
Renal
Uric acid calculi (seen in10-15% of gout pts)
Chronic urate nephropathy (in those with tophi)
Acute uric acid nephropathy (in pts undergoing
chemotherapy)
Hypertensive Renal disease is the most common
cause of renal disease in gout
Management of
Chronic tophaceus arthritis
Advise to correct predisposing condition
Prophylactic colchicine or low dose
NSAID
Longterm urate lowering Tx
Uric Acid
Random hyperuricemia gout (likely CRI, diuretic
use)
Acute attack: Urate levels may be normal, low or
high
40-49% of acute gouty attacks normouricemic
Mechanism: increased excretion of uric acid
Probably mediated by IL-6, inflammation
Urano W, et al. J Rheumatol 29:1950-3, 2002
Schlesinger N, et al. J Rheumatol 24: 2265-6, 1997
TheAmericanDiet/fastfood&itsconsequences
Obesity, Metabolic
Syndrome
and Gout
PRINCIPAL FEATURES OF
METABOLIC SYNDROME
ELEVATED CIRCULATING INSULIN LEVELS
INSULIN RESISTANCE
GLUCOSE INTOLERANCE OR TYPE II DM
ABDOMINAL (VISCERAL) OBESITY: defined as waist
circumference > 40 inches in men (>35 inches in females)
DYSLIPIDEMIA (Hypertriglyceridemia&low HDL chol)
HYPERTENSION
HYPERURICEMIA
INCREASED RISK OF ATHEROSCLEROSIS AND
COAGULATIVE ARTERIAL OCCLUSIVE EVENTS
mia Stimulates
Increased
Renal Sodium
and
Urate
Reabsorption
A Mild Defect
in Renal
Ammonium
Excretion
Associated
with IR
Promotes Acid
Milieu for Uric
Acid
Urolithiasis
Urate
pH
1.
2.
3.
4.
.
REVIEW
Prevention Prescription
Encourage weight loss and maintenance of a healthy body
mass index.
Decrease consumption of red meat and most seafood.
Increase intake of vegetables, legumes, nuts, and vegetable
proteins.
Decrease intake of sugar-containing beverages and
fructose.
Limit alcohol to no more than 1-2 drinks per day and drink
wine rather than beer or liquor.
Increase intake of low-fat dairy, up to two servings per day.
Maintain adequate hydration.
Fructose
present in honey and fruit
50% of sugar (sucrose = 1 glucose +
1 fructose molecule)
55% of HFCS ( high fructose corn
sryup)
Results
1 servings a day increased
risk by 45%
Suggests that the risk posed by free fructose intake , is as great as that of
the intake of purine rich food
ATP
fructose
Fructokinase
Fructose -1-
ADP
AMP
phosphate
AMP
Deaminase
IMP
URIC ACID
Liver Cell
ATP
fructose
Fructokinase
Fructose -1phosphate
ADP
AMP
AMP
Deaminase
IMP
Aldolase B
DHA phosphate
URIC ACID
Liver Cell
NSAIDs
1st choice
Rapid acting (naproxen, indomethacine) preferred
Continued until 48h after absence of inflammation
2. Colchicine
Alternative, out-dated
Time limit: effective between 12-36h of an attack
0.6mg q 1h up to 10 doses until relief of joint Sx or
G-I Sx
3. Intraarticular corticosteroid:
Effective in monoarticular gout
4. Systemic corticosteroid
When NSAIDs are not effective or
contraindicated
Colchicine
Corticosteroid
P.O;20-40mg/day for 34days, then taper one to
2 weeks
Intraarticular injection:
triamcinolone 10-40mg or
deaxamethasone 2-10mg
with lidocaine
In:
recalcitrant acute gout
hepatopathy
elderly patients with
renal insufficiency
Correction of hyperuricemia
Indications
Quercetin
Inhibits xanthine oxidase
Decreases BP and oxidized LDL
onions, apples, berries, grapes, green
and black tea, citrus fruits, capers,
tomatoes, broccoli, and leafy greens
Supplement with 500mg
Turmeric
EFAs
Ginger
Rosemary
Nuts
Greens
Tea
Citrus
Rosemary
Cherries
Cold-Water Fish, Flax, Walnuts, Leafy
Greens
Onions, apples, berries, tea, broccoli,
tomatoes, grapes.
Pineapple
Acupuncture
Needles Vs. Allopurinol +
Indomethacin
93% effective vs. 80%
Greater reductions in serum uric acid
Fewer adverse effects
Ice
Most arthritic conditions benefit from
heat
patients with gout prefer ice.[38]
Treatment: MEDS
Prevention
An ounce of Prevention is
worth a pound of cure
Behold the rain which
descends from heaven upon our
vineyards, there it enters the
roots of the vines, to be
changed into wine, a constant
proof that God loves us, and
loves to see us happy
SUMMARY
The disease burden of gout remains substantial
and may be increasing.
As more scientific data on modifiable risk factors
and comorbidities of gout become available,
integration of these data into gout care strategy
may become essential, similar to the current care
strategies for hypertension and type 2 diabetes.
Recommendations for lifestyle modification to
treat or to prevent gout are generally in line with
those for the prevention or treatment of other
major chronic disorders
Weight control, limits on red meat consumption,
and daily exercise are important foundations of
lifestyle modification recommendations
Plant-derived -3 fatty acids or supplements
of eicosapentaenoic acid and docosahexanoic
acid instead of consuming fish for cardiovascular
benefits.
SUMMARY
Further riskbenefit assessments in
each specific clinical context would be
helpful.
Daily consumption of nuts and legumes
as recommended by the Harvard
Healthy Eating Pyramid (32) may also
provide important health benefits without
increasing the risk for gout.
Similarly, a daily glass of wine may
benefit health without imposing an
elevated risk for gout, especially in
contrast to beer or liquor consumption.
These lifestyle modifications are
inexpensive and safe and, when combined
with drug therapy, may result in better
SUMMARY
Effective management of gout risk factors
(for example, hypertension) and the
antihypertensive agents with uricosuric
properties (for example, losartan or
amlodipine could have a better risk
benefit ratio than diuretics for
hypertension in hypertensive patients with
gout.
Similarly, the uricosuric property of
fenofibrate may be associated with a
favorable risk benefit ratio among
patients with gout and the metabolic
syndrome.
SUMMARY
The recently elucidated molecular mechanism of
renal urate transport has several important
implications in conditions that are associated with
high urate levels.
In particular, the molecular characterization of
the URAT1 anion exchanger has provided a
specific target of action for well known
substances affecting urate levels.
Genetic variation in these renal transporters or
upstream regulatory factors may explain the
genetic tendency to develop conditions
associated with high urate levels and a patients
particular response to medications.
Furthermore, the transporters themselves may
serve as targets for future drug development.